Meinig, Richard
Jarvis, Stephanie
Salottolo, Kristin
Nwafo, Nnamdi
McNair, Patrick
Harrison, Paul
Morgan, Steven
Duane, Therese
Woods, Bradley
Nentwig, Michelle
Kelly, Michael
Cornutt, David
Bar-Or, David
Article History
Received: 1 February 2022
Accepted: 8 February 2023
First Online: 21 July 2023
Declarations
:
: Four institutional review boards (IRB), representing all six centers, approved of this study: CommonSpirit Health Research Institute (No. 1238705), Hospital Corporation of America HealthONE (No. 1238702), Medical City Plano (No. 1238693), and Western IRB (No. 20181371). This study was approved with a waiver of consent.
: Not applicable.
: Dr. David Cornutt is a consultant for Alexion Pharmaceuticals and Portola Pharmaceuticals; no other authors have any competing interests or financial disclosures to declare.